ToxoTech AB
559234-1456ActiveDeveloping precision-engineered next-generation botulinum neurotoxin therapeutics for neurological disorders.
Översikt
- 1
- Anställda
- 738t SEK
- Omsättning
- 2019
- Grundat
Nyckelbeslutsfattare
Jonathan Ilicki
Board Member
Geoffrey Masuyer
CEO
Pål Stenmark
Vice-CEO
Ellen Walse
Scientist
+1 fler kontakter i Funnelfeedr
Beskrivning
ToxoTech is a Stockholm-based biopharmaceutical company founded in 2020 as a spin-out from Stockholm University. The organization specializes in advancing the science behind next-generation botulinum neurotoxin (BoNT) therapeutics. Their core technology focuses on engineering improved toxin-receptor...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559234145601
Beslutsfattare
5 kontakter i FunnelfeedrJonathan Ilicki
Board Member
Geoffrey Masuyer
CEO
Pål Stenmark
Vice-CEO
Övriga kontakter
Ellen Walse
Scientist
Sara Persson Košenina
Principal Scientist
Liknande företag
20 liknande företag i Funnelfeedr
MERZ THERAPEUTICS NORDICS AB
Nordic therapeutics company specializing in neurological movement disorder treatments.
MitoTech AB
0 anställdaDeveloping novel small molecules to restore mitochondrial function in diseases.
AB MAvatar
22 anställdaAI platform transforming biomedical data into personalized medicine insights.
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
Tablestat Technologies Nordic AB
1–4 anställdaAI-powered platform for deal sourcing, buyer mapping, and valuation.
Utforska mer
Frågor om ToxoTech AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo